Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
181
Employees181
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
181
Employees181

FATE Key Statistics

Market cap
137.85M
Market cap137.85M
Price-Earnings ratio
-0.91
Price-Earnings ratio-0.91
Dividend yield
Dividend yield
Average volume
1.48M
Average volume1.48M
High today
$1.20
High today$1.20
Low today
$1.20
Low today$1.20
Open price
$1.17
Open price$1.17
Volume
256.00
Volume256.00
52 Week high
$1.94
52 Week high$1.94
52 Week low
$0.6611
52 Week low$0.6611

Stock Snapshot

Fate Therapeutics(FATE) stock is priced at $1.20, giving the company a market capitalization of 137.85M. It carries a P/E multiple of -0.91.

On 2026-02-13, Fate Therapeutics(FATE) stock moved within a range of $1.20 to $1.20. With shares now at $1.20, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 256, compared to an average daily volume of 1.48M.

Over the past 52 weeks, Fate Therapeutics(FATE) stock has traded between a high of $1.94 and a low of $0.66.

Over the past 52 weeks, Fate Therapeutics(FATE) stock has traded between a high of $1.94 and a low of $0.66.

Analyst ratings

55%

of 11 ratings
Buy
45.5%
Hold
54.5%
Sell
0%

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.